Related Experiment Video
Updated: Jul 18, 2026

Microfluidic Genipin Deposition Technique for Extended Culture of Micropatterned Vascular Muscular Thin Films
Published on: June 26, 2015
Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways
Michael A Crackower1, Gavin Y Oudit, Ivona Kozieradzki
1IMBA, Institute for Molecular Biotechnology of the Austrian Academy of Sciences, c/o Dr. Bohr Gasse 7, A-1030, Vienna, Austria.
Abstract:
The PTEN/PI3K signaling pathway regulates a vast array of fundamental cellular responses. We show that cardiomyocyte-specific inactivation of tumor suppressor PTEN results in hypertrophy, and unexpectedly, a dramatic decrease in cardiac contractility. Analysis of double-mutant mice revealed that the cardiac hypertrophy and the contractility defects could be genetically uncoupled. PI3Kalpha mediates the alteration in cell size while PI3Kgamma acts as a negative regulator of cardiac contractility. Mechanistically, PI3Kgamma inhibits cAMP production and hypercontractility can be reverted by blocking cAMP function. These data show that PTEN has an important in vivo role in cardiomyocyte hypertrophy and GPCR signaling and identify a function for the PTEN-PI3Kgamma pathway in the modulation of heart muscle contractility.
Insights
The PTEN/PI3K pathway impacts heart cell size and function. PTEN loss causes hypertrophy and reduced contractility, with PI3Kgamma regulating contractility via cAMP signaling.
Area of Science:
- Cardiovascular Biology
- Molecular Signaling
- Cellular Physiology
Background:
- The Phosphatase and Tensin homolog (PTEN) and Phosphoinositide 3-kinase (PI3K) signaling pathway is crucial for regulating cellular processes.
- Dysregulation of this pathway is implicated in various cardiovascular diseases.
Purpose of the Study:
- To investigate the in vivo role of PTEN in cardiomyocyte hypertrophy and cardiac function.
- To elucidate the specific roles of different PI3K isoforms in mediating PTEN's effects on the heart.
Main Methods:
- Utilized cardiomyocyte-specific PTEN knockout mouse models.
- Generated and analyzed double-mutant mice to genetically uncouple hypertrophy and contractility defects.
- Investigated the involvement of PI3K isoforms (PI3Kalpha and PI3Kgamma) and cyclic AMP (cAMP) signaling.
Main Results:
- Cardiomyocyte-specific PTEN inactivation led to cardiac hypertrophy and a significant decrease in cardiac contractility.
- Cardiac hypertrophy and contractility defects were found to be genetically separable.
- PI3Kalpha mediated changes in cardiomyocyte size, while PI3Kgamma negatively regulated cardiac contractility.
- PI3Kgamma's inhibition of cardiac contractility was linked to suppressed cAMP production, and hypercontractility could be restored by blocking cAMP function.
Conclusions:
- PTEN plays a vital role in regulating cardiomyocyte hypertrophy and G protein-coupled receptor (GPCR) signaling in vivo.
- The PTEN-PI3Kgamma pathway is identified as a key modulator of heart muscle contractility.
- Specific PI3K isoforms have distinct roles in cardiac physiology, highlighting therapeutic targets for cardiovascular conditions.
More Related Videos
09:08Precision Cut Lung Slices as an Efficient Tool for Ex vivo Pulmonary Vessel Structure and Contractility Studies
Published on: May 24, 2021
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
IP3/DAG Signaling Pathway